Manufacturer record
Askon Health Care: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
8 batches manufactured by Askon Health Care (Madhya Pradesh) were declared Not of Standard Quality between November 2022 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: IBK-2601, Ibuprofen Tablets IP 400 mg (exp Jan 2029). SDTL, Agartala, Tripura (state lab) found it not of standard quality: The sample does not conform to standard quality in respect of the test for ?Dissolution? performed. Listed in the September 2026 alert.
Records by type
8 records linked to Askon Health Care in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ibuprofen Tablets IP 400 mg | Batch IBK-2601Mfg Feb 2026 · Exp Jan 2029 | The sample does not conform to standard quality in respect of the test for ?Dissolution? performed.Dissolution | SDTL, Agartala, TripuraState lab | Sep 2026 |
| Ibuprofen &Paracetamol Tablets IP | Batch KFM-2501Mfg Mar 2025 · Exp Feb 2028 | The sample does not conform to standard quality in respect of the test for ?Dissolution? and Description performed.Dissolution | SDTL, Agartala, TripuraState lab | Sep 2026 |
| Ibuprofen & Paracetamol Tablets IP | Batch KFM-2502Mfg Sep 2025 · Exp Aug 2028 | The sample does not conform to standard quality in respect of the test for Description performed.Description | SDTL, Agartala, Govt. of TripuraState lab | Aug 2026 |
| Ibuprofen Tablets IP 400 mg | Batch IBK-2503Mfg Jun 2025 · Exp May 2028 | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Ibuprofen.Dissolution | RDTL, GuwahatiCDSCO lab | Jun 2026 |
| Riboflavin Tablets IP 5 mg | Batch RB-2433Mfg Nov 2024 · Exp Oct 2027 | The sample does not conform to I.P.w.r.t. the tests for Dissolution.Dissolution | SDTL, AssamState lab | Mar 2026 |
| Riboflavin Tablets IP 5 MG | Batch RB-2433Mfg Nov 2024 · Exp Oct 2027 | The sample does not conform to I.P. w.r.t. the tests for Dissolution.Dissolution | SDTL, AssamState lab | Feb 2026 |
| Paracetamol 500 mg. Tablets | Batch PAR-31Mfg Aug 2023 · Exp Jul 2026 | The sample Does not Complies conforms to I.P. with respect to the above tests only.Other | RDTL GuwahatiCDSCO lab | May 2024 |
| Primaquine Phosphate Tablets IP | Batch PQH-08Mfg Nov 2021 · Exp Oct 2024 | AssayAssay | RDTL GuwahatiState lab | Nov 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.